Clinical Trial

Phase 2b Controlled Study of Dosing Techniques - Part B

Name: Phase 2b Controlled Study of Dosing Techniques - Part B — clinical trial record (NCT07161011)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 2

View on ClinicalTrials.gov →

Summary

Double-masked, dose-response of two concentrations of IVW-1001

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2025-08-29; most recent amendment 2026-03-24.

Status change: Active, Not Recruiting → Completed 2026-03-24

Status change: Not Yet Recruiting → Active, Not Recruiting 2025-09-18

Trial Details

NCT Number	NCT07161011
Lead Sponsor	IVIEW Therapeutics Inc.
Conditions	Dry Eye
Enrollment	15 participants
Start Date	2025-09-08
Primary Completion	2025-11-03 (estimated)
Study Completion	2025-11-03 (estimated)
Updated on ClinicalTrials.gov	2026-03-27